Taysha Gene Therapies logo
Taysha Gene Therapies TSHA
$ 2.15 6.72%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Taysha Gene Therapies ROCE Ratio 2011-2024 | TSHA

Annual ROCE Ratio Taysha Gene Therapies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-96.67 -17117.7 -181.65 -17.08 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-17.08 -17117.7 -4353.28

Quarterly ROCE Ratio Taysha Gene Therapies

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-60.83 1.43 84.0 206.87 -30.98 -301.92 -467.59 -438.37 -474.46 -272.71 -191.91 -72.36 -78.34 -48.23 -27.96 -9.8 816.12 845.07 846.67 848.89 22.96 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
848.89 -474.46 56.98